BioLineRx Ltd. (BLRX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BioLineRx Ltd.

    NASDAQ: BLRX · Real-Time Price · USD
    3.84
    0.05 (1.32%)
    At close: Sep 26, 2025, 3:59 PM
    3.85
    0.26%
    After-hours: Sep 26, 2025, 06:31 PM EDT

    BioLineRx Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -74.15 -66.54 -48.8 -133.3
    PEG Ratio
    		 0.84 -0.7 2.32 2.02
    PS Ratio
    		 23.63 840.27 n/a n/a
    PB Ratio
    		 50.79 305.02 23.95 52.97
    P/FCF Ratio
    		 -15.56 -176.09 -45.85 -152.36
    P/OCF Ratio
    		 -15.58 -178.4 -46.41 -152.99
    OCF/S Ratio
    		 -1.52 -4.71 n/a n/a
    Debt / Equity Ratio
    		 1.12 0.88 0.24 0.07
    Quick Ratio
    		 1.56 1.06 4.85 5.89
    Current Ratio
    		 1.76 1.10 4.87 5.91
    Asset Turnover
    		 0.74 0.08 n/a n/a
    Interest Coverage
    		 -2.25 -22.91 -13.51 -25.18
    Return on Equity
    		 -0.69 -4.58 -0.49 -0.4
    Return on Assets
    		 -0.24 -0.95 -0.33 -0.33
    Return on Invested Capital
    		 -0.72 -2 -0.43 -0.33
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.68 0.23 n/a n/a
    Net Profit Margin
    		 -0.32 -12.63 n/a n/a
    Pretax Profit Margin
    		 -0.32 -12.63 n/a n/a
    Operating Profit Margin
    		 -0.71 -10.35 n/a n/a
    FCF Margin
    		 -1.52 -4.77 n/a n/a
    EBITDA Margin
    		 0.14 -11.89 n/a n/a

    Add to Watchlist